Additional studies of WFDC2 could provide significant information as to its potential pathophysiological actions in ovarian cancer progression and might lead to novel strategies for tumor treatment in patients treated with anti-estrogens. This evidence concerns the gene WFDC2 and ovarian carcinoma.